1. Home
  2. SNDL vs RXST Comparison

SNDL vs RXST Comparison

Compare SNDL & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SNDL Inc.

SNDL

SNDL Inc.

N/A

Current Price

$1.54

Market Cap

386.3M

Sector

Health Care

ML Signal

N/A

Logo RxSight Inc.

RXST

RxSight Inc.

N/A

Current Price

$7.55

Market Cap

307.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNDL
RXST
Founded
2006
1997
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
386.3M
307.6M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
SNDL
RXST
Price
$1.54
$7.55
Analyst Decision
Strong Buy
Hold
Analyst Count
1
11
Target Price
$5.00
$11.50
AVG Volume (30 Days)
897.6K
710.0K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$134,479,000.00
Revenue This Year
$5.48
N/A
Revenue Next Year
$3.41
$8.69
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$6.62
52 Week High
$2.89
$27.13

Technical Indicators

Market Signals
Indicator
SNDL
RXST
Relative Strength Index (RSI) 46.87 37.11
Support Level $1.44 $7.34
Resistance Level $1.60 $9.11
Average True Range (ATR) 0.06 0.50
MACD 0.01 -0.01
Stochastic Oscillator 46.23 20.41

Price Performance

Historical Comparison
SNDL
RXST

About SNDL SNDL Inc.

SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.

About RXST RxSight Inc.

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Share on Social Networks: